Related Experiment Video
Updated: May 9, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Management of hereditary angioedema
1The Royal London Hospital, London. john.dempster@bartshealth.nhs.uk
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|August 7, 2013
Summary
Newly approved C1 inhibitors allow self-administration for hereditary angioedema patients. This empowers proactive disease management and reduces the overall illness burden, improving patient quality of life.
Area of Science:
- Immunology
- Genetics
- Pharmacology
Background:
- Hereditary angioedema (HAE) presents with unpredictable, severe swelling.
- HAE significantly impacts patient quality of life and necessitates effective management strategies.
Purpose of the Study:
- To discuss the impact of newly approved C1 inhibitors for self-administration in HAE management.
- To explore the benefits of proactive HAE treatment from a specialist nurse's viewpoint.
Main Methods:
- Review of recent advancements in HAE therapeutics.
- Analysis of the role of specialist nurses in patient education and support for self-administered treatments.
Main Results:
- Self-administration of C1 inhibitors enables proactive HAE management.
- Improved patient autonomy and reduced disease burden are key outcomes.
- Specialist nurses play a crucial role in facilitating the adoption of new therapies.
Conclusions:
- Recent C1 inhibitor approvals represent a significant advancement in HAE care.
- Patient empowerment through self-administration enhances disease control and well-being.
- The evolving role of specialist nurses is vital for optimizing outcomes in hereditary angioedema.
Related Concept Videos
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...